NDC product
MONTELUKAST SODIUM ORAL
NDC 13668-531 · TORRENT PHARMACEUTICALS LIMITED
Key facts
| Product NDC | 13668-531 |
|---|---|
| Proprietary name | MONTELUKAST SODIUM ORAL |
| Labeler | TORRENT PHARMACEUTICALS LIMITED |
| Marketing category | ANDA |
| Application number | ANDA210431 |
| Marketing start | Mar 30, 2017 |
| Marketing end | Sep 9, 2022 |
| Listing certified through | Sep 9, 2022 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: